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Abstract
Disorders of the lungs such as chronic obstructive pulmonary disease (COPD) are a major
cause of chronic morbidity and mortality and the third leading cause of death in the world.
The absence of sensitive diagnostic tests for early disease stages of COPD results in
under-diagnosis of this treatable disease in an estimated 60–85% of the patients. In recent
years a grating-based approach to X-ray dark-field contrast imaging has shown to be very
sensitive for the detection and quantification of pulmonary emphysema in small animal mod-
els. However, translation of this technique to imaging systems suitable for humans remains
challenging and has not yet been reported. In this manuscript, we present the first X-ray
dark-field images of in-situ human lungs in a deceased body, demonstrating the feasibility of
X-ray dark-field chest radiography on a human scale. Results were correlated with findings
of computed tomography imaging and autopsy. The performance of the experimental radi-
ography setup allows acquisition of multi-contrast chest X-ray images within clinical bound-
ary conditions, including radiation dose. Upcoming clinical studies will have to demonstrate
that this technology has the potential to improve early diagnosis of COPD and pulmonary
diseases in general.
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Introduction
Lung diseases, such as chronic obstructive pulmonary disease (COPD), lower respiratory
infections and lung cancer are some of the most common medical conditions in the world.
According to the most recent (2015) world health organization (WHO) data [1], COPD ranks
level with lower respiratory infections as the third leading cause of death globally, claiming
over 3 million lives each year (5.7% of all deaths). At the same time, early diagnosis of COPD is
challenging, as spirometry is highly dependent on the patient’s cooperation and conventional
chest radiographs have poor to moderate sensitivity. As treatment options for late stage COPD
are limited, it is of major importance to improve diagnostics of COPD and lung diseases in
general.
Since its clinical introduction in the early 1900s, the principle of image contrast formation
in conventional X-ray imaging has solely been based on X-ray attenuation. Due to similar tis-
sue properties in terms of the interaction mechanism with X-rays, soft-tissue contrast is low in
conventional radiography (and computed tomography) and limits diagnostic capabilities.
However, attenuation is not the only physical effect X-rays experience when travelling through
an object. Additionally, X-rays have wave properties and are thus subject to effects like refrac-
tion and ultra small-angle scattering (which leads to dark-field contrast). Those effects cannot
be visualized with a conventional X-ray imaging system. Different approaches have been devel-
oped to measure these material- and structure-specific properties and therewith provide com-
plementary information to conventional X-ray images [2–4]. A recently developed technique
that is based on a three grating interferometer arrangement [5–7] appears to be particularly
promising, as its implementation is feasible with any X-ray source and detector typically used
in clinical environments. The method has already been implemented in several experimental
setups [8,9], a prototypical pre-clinical mammography demonstrator system [10], a radio-
graphic projection system for osteoarthritis diagnosis in finger joints [11], and a first in-vivo
dark-field small-animal CT system[12].
Dark-field image contrast is generated by multiple refractions on microstructures in the
object (ultra small-angle scattering), which are on a significantly smaller scale in comparison
to the spatial resolution of the imaging system. With this in mind, one can imagine that the
dark-field signal indirectly reveals structural information on the micrometer length scale
[6,13] that is inaccessible with conventional medical X-ray systems. Particularly the lungs
exhibit a strong signal, as their main morphological structures–the alveoli–have a typical size
of a few tens of micrometers with many air-tissue interfaces [12]. A schematic sketch of the
experimental assembly (A) and its basic functional principle (B) are displayed in Fig 1.
Based on the first successful pre-clinical in-vivo proof-of-principle experiments [12], several
small-animal models of pulmonary diseases have been investigated recently to assess the diag-
nostic potential of the dark-field modality. In a murine in-vivo model X-ray dark-field radiog-
raphy showed a substantial improvement over conventional attenuation-based X-ray imaging
for the diagnosis of pulmonary emphysema [14]. Notably, in a follow-up study X-ray dark-
field radiography could reliably visualize different stages of emphysema in-vivo and demon-
strated higher diagnostic accuracy for early stages of emphysema than conventional attenua-
tion-based radiography [15]. Apart from COPD imaging preclinical X-ray dark-field
radiography has shown high sensitivity for the detection and/or quantification of other pulmo-
nary diseases like pulmonary fibrosis [16], pneumothorax [17] and neonatal lung injury [18].
Based on the preclinical in-vivo results, it is reasonable to argue that X-ray dark-field radiogra-
phy may not only improve detection of early disease stages of COPD, but may also allow moni-
toring and staging of disease progression, as well as therapy response evaluation by means of
the additional information on microstructural changes. However, a demonstration of X-ray
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dark-field imaging compatible with clinical demands in terms of image quality, scan duration,
field-of-view, large object penetration and radiation dose has not been reported so far due to a
number of challenges. We have overcome most of these challenges and have developed an
experimental prototype [19] to evaluate the wave properties of X-ray imaging for future medi-
cal diagnostic applications. The purpose of this study was to demonstrate the feasibility of
human pulmonary X-ray dark-field imaging in a lately deceased body and to correlate results
with computed tomography.
Fig 1. Human X-ray dark-field prototype chest scanner. (A) The X-ray chest scanner combines a three-grating arrangement (with an oblong
active area) with a continuous line-scanning approach, with the purpose of imaging an entire human thorax. By scanning the active area over the
field of view, every pixel is sampled at various phases of the Moire´ pattern, allowing retrieval of attenuation, differential-phase, and dark-field
information. In order to simulate in-vivo conditions and demonstrate clinical relevance of the presented results, tracheal intubation was performed
on the deceased body and the lungs were inflated at 23 mbar during measurement. (B) X-ray dark-field contrast is generated by ultra small-angle
scattering for instance at air-tissue interfaces of lung alveoli. Scattering causes blurring (red) of the initially well-delimited (black) intensity pattern
generated by G1 resulting in a reduction of the measured visibility. Note that several slit sources contribute to the intensity value at any specific
location in front of G2. For sake of simplicity, only a few rays passing trough one G1 slot are shown for illustrational purposes.
https://doi.org/10.1371/journal.pone.0204565.g001
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Materials and methods
The experiment was conducted in accordance with the Declaration of Helsinki and was
approved by the institutional review board (Ethikkommission der Ludwig-Maximilians-Uni-
versita¨t Mu¨nchen, Pettenkoferstr. 8a, 80336 Mu¨nchen). As inclusion criteria for the study,
average demographic parameters in size and weight were defined for the deceased human
body. The investigated female body had a size and weight of 173 cm and 84 kg, respectively.
Imaging was performed 36h post mortem.
Within this study, we present the first dark-field chest radiography of a deceased human
body as a proof-of-principle study for the translation of X-ray dark-field imaging towards clin-
ical application. Underlying specifications and an overview of the image acquisition procedure
are given in the following. Additionally, we present a descriptive explanation of the general
concept and physical mechanisms of X-ray dark-field imaging.
X-ray grating interferometry
Fig 1A shows a schematic of the human X-ray dark-field thorax scanner. The scanner utilizes
an imaging technique presented earlier by Pfeiffer et al. [5]. A three grating arrangement is
used in combination with a conventional clinical X-ray source and an X-ray detector [5,6] in
order to obtain an X-ray system that is sensitive to ultra small-angle scattering (dark-field)
properties of the samples. The first grating downstream of the patient (G1) generates a periodic
intensity pattern that can be analyzed by means of a second absorption grating (G2), as the pat-
tern as such cannot be directly resolved with a clinical detector. Typically, the intensity pattern
can be sampled in a step-wise manner by translating one of the gratings and acquiring images
at intermediate positions. The retrieved intensity curve, also referred to as the stepping curve,
yields information on the sample’s attenuation, differential phase, and ultra small-angle scat-
tering properties with respect to X-rays. To extract the relevant signals from the measured
curve, Fourier analysis or (as in our case) a least squares fit is performed. The oscillation
strength of the intensity pattern normalized to its mean value, the so-called visibility, is the
determining performance parameter in grating-based X-ray imaging.
Additionally, as the focal spot is large compared to the period of the intensity pattern, a
third grating has to be introduced in order to shape the large source spot (1.2 mm in our case)
into several partially coherent slit sources. The inter-grating distances and grating periods
must fulfill the intercept theorem as described in Ref. [5]. The source to detector distance of
our system measures 2010 mm.
X-ray dark-field image contrast
Objects with strong electron density fluctuations on the micron and sub-micron scale cause
ultra small-angle X-ray scattering due to repeated refraction on interfaces of the inherent
micromorphology. Ultra small-angle scattering causes blurring of the intensity pattern gener-
ated by G1 and consequently leads to a reduction in measured visibility. The underlying mech-
anism is schematically illustrated in Fig 1B: Here X-rays are refracted at air-tissue interfaces of
lung alveoli, which subsequently causes blurring (red curve) of the originally well distinguish-
able intensity pattern (black curve). As proposed by Pfeiffer et al. [6], this entity can be mea-
sured with a three-grating interferometer and was named—in analogy to visible light and
electron microscopy—X-ray dark-field contrast.
The ultra small-angle scattering power of a certain material, which is determined by both
chemical and structural properties, is described by the so-called linear diffusion coefficient [7].
Similar to the Lambert-Beer law of attenuation, the visibility shows an exponential decay with
object thickness [7]. We therefore present the dark-field radiographies as the negative
X-ray dark-field imaging of the human lung—A feasibility study on a deceased body
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logarithm of the relative change in visibility to visualize the integrated lung-specific linear dif-
fusion coefficient. Detailed considerations of X-ray dark-field contrast generation and its
dependence on structural parameters can be found in Refs. [13,20]
At present, contrast formation in clinical radiography solely relies on the attenuation prop-
erties of the investigated region of interest. In the case of the human thorax, the assessment of
the lung on a radiographic basis is therefore limited, as the lung contrast is inherently low and
surrounding/superimposing tissue (bones, fat, and muscle) dominate the signal. Conse-
quently, it is only possible to identify variations in global lung pattern as such, rather than
assessing its alveolar structure and potential (early) disorders of the latter. To visualize this
aspect, Fig 2 shows the attenuation and dark-field images of two open cell melamine sponges
(dry and drenched with water), which were imaged with our prototype system. Similar to the
human lung, a fine-pored melamine sponge consists of thousands of air-tissue interfaces
which causes significant ultra small-angle X-ray scattering and therefore exhibits a distinct
dark-field signal (Fig 2B). At the same time, comprising porous structures, both lung and
sponge yield a low overall density and appear radiolucent in the attenuation channel (Fig 2A).
When drenching the foam, air is displaced by water and the surfaces become wet; hence, the
initial high variation of the refraction index within the sample becomes neutralized, and the
dark-field signal strength decreases distinctly. Additionally, water is more attenuating in com-
parison to air, explaining an inversion of both contrast modalities.
This basic phantom study illustrates the potential of multimodal imaging for clinical diag-
nostics: by probing two different physical mechanisms, complementary image information
can be retrieved. Samples that still appear radiolucent in attenuation-based imaging can be
assessed by dark-field radiography via detection of ultra small-angle scattering due to inherent
substructures. In studies involving the lung, this information has been demonstrated to encode
physiological properties of the organ as dark-field intensity correlates well with the number of
Fig 2. Complementarity of X-ray attenuation and dark-field radiography. X-ray attenuation (A) and dark-field (B) signal of dry
(upper) and water drenched (lower) open cell melamine sponges. Similar to the human lung, a fine-pored melamine sponge comprises
thousands of air-tissue interfaces and causes strong ultra small-angle X-ray scattering and therefore exhibits a distinct dark-field signal. At
the same time, comprising porous structures, both lung and sponge yield small overall densities and appear radiolucent in the attenuation
channel. When drenching the foam, air is displaced by water resulting in a high contrast in the attenuation channel due to stronger
attenuation in comparison to air. Simultaneously, the interfaces become neutralized, explaining an inversion of both contrast modalities.
The image acquisition protocol except for the tube current was similar to the one of the dead body scan (70 kVp, 100mA, 20 ms exposure
time per pulse, 12 Hz pulse frequency, 3x3 pixel binning).
https://doi.org/10.1371/journal.pone.0204565.g002
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intact alveolar interfaces [21]. This motivates us to consider dark-field imaging as a functional
medical imaging tool.
Preparations
Tracheal intubation was performed on the deceased human body and the lungs were inflated
with 23 mbar during measurement. This was done with the purpose of restoring ultra small-
angle scatter-active interfaces by partially reverting a collapse of lung alveoli, considering mea-
surements were conducted 36 hours after death, at which point post-mortem changes to the
lung parenchyma are to be expected.
Large field of view—Scanning data acquisition procedure
To image an entire human thorax, the image acquisition was realized with a continuous scan-
ning approach using an oblong, stitched grating covering an area of 2.5 x 40 cm2. The underly-
ing image acquisition procedure is similar to the method proposed by Kottler et al. [22]:
Instead of stepping one of the gratings between intensity recordings, the relative shifts of the
intensity pattern with respect to the G2 grating are intrinsically encoded within the field-of-
view of the interferometer. For this reason, low frequency Moire´-fringes were purposefully cre-
ated by inducing a slight period mismatch between the G1 and the G2 grating. When the inter-
ferometer and the sampling pattern is then moved in relation to the specimen, its integrated
X-ray interaction is recorded at various relative grating to intensity pattern positions for each
pixel by consecutive intensity measurements with the detector over the course of the scan. The
obtained curve corresponds to the registered intensity in a pixel as a function of the interfer-
ometer position and is equivalent to the conventional stepping curve mentioned before.
Adapted to our geometry and scanning procedure, the algorithm utilized for retrieving both,
attenuation and dark-field signal is similar to the one described in Ref [10]. No spatial resort-
ing process is required prior to analyzing the stepping curve.
Since a conventional X-ray source is used, the underlying spectrum is highly polychromatic.
As a consequence, the scanner is susceptible to spectral effects, so that the system visibility is
dependent on sample thickness and material. Comparable considerations on this topic can be
found in Ref. [23]. To account for these so-called beam-hardening effects, the relative visibility
is corrected by a calibration factor previously obtained by a series of visibility measurements
with an equivalent absorbing material (polyoxymethylene or POM) that mimics the spectral
influences of the cadaver on the X-ray spectrum.
Grating production and alignment
The grating structures were manufactured utilizing X-ray lithography processes [24] (KIT and
microworks GmbH, Karlsruhe, Germany). In order to obtain oblong grating arrays for G1 and
G2 an approach as described in [25] was utilized. Hereby, eight individual grating tiles (2.5 x 5
cm2) for each plane were stitched together under microscope observation. Within the scanner
the individual tiles as well as assembled grating array were aligned and positioned relative to
each other to fulfill the geometrical constraints indicated in Fig 1B. The scanner achieves a
mean visibility of about 32% over the entire field-of-view.
X-ray components and operational parameters
The X-ray source, a Philips SRO1750ROT360 (Philips Medical Systems DMC GmbH, Ham-
burg, Germany) is operated at 70 kVp voltage, 400 mA tube current and 12 Hz pulse fre-
quency. That choice of acceleration voltage is a compromise between the achieved visibility
X-ray dark-field imaging of the human lung—A feasibility study on a deceased body
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and a reasonable transmission through a human thorax. With increasing X-ray energies, the
visibility decreases as the gratings become more transparent. Furthermore, the spectrum
becomes broader–both negatively affecting the image quality of the dark-field image. A Pixium
RF 4343 (Trixell, Moirans, France) flat-panel detector with a pixel size of 148 x 148 μm2 is
operated in a 3x3-binning mode. The exposure time per pulse was set to 20 ms. With a scan-
speed of approximately 11 mm/s the entire human thorax was scanned within 30 seconds,
which corresponds to 354 pulses total. Both X-ray tube and detector are standard components
of medical radiographic imaging systems. The effective field of view with respect to the posi-
tion of the deceased body that is achievable with these parameters and the earlier mentioned
active grating area is 28 x 32 cm2.
CT Image acquisition, reconstruction and radiation dose
CT imaging was performed on a 256-slice medical CT-scanner (Brilliance iCT, Philips Health-
care, Best, The Netherlands). The deceased body was placed in supine position in the gantry
isocenter. Two localizer radiographs were acquired to plan the chest CT. Imaging was per-
formed at 120 kVp, using 1280.625 mm collimation, 0.664 pitch, 0.33 s gantry rotation time,
spiral acquisition mode and Dose Right Index 5. The tube output was 28 mAs, Images were
reconstructed by help of iDose4(Philips Healthcare, Best, The Netherlands). The volume com-
puted tomography dose index was 1.9 mGy and dose line product was 76.3 mGycm.
Dose considerations
The scanner was designed to be compatible with the strict dose regulations of clinical radiogra-
phy. According to Wall et al.[26] the average values of effective dose deposition in posterior-
anterior (PA) X-ray chest imaging is 0.014 mSv and 0.038 mSv in lateral (LAT) orientation.
First, a slot collimation was implemented to limit the X-ray beam to the active grating region.
Second, and in order to absorb dose-critical low-energy photons from the incident beam 2.5
mm of aluminum equivalent filtration was used. Third, by synchronizing the detector mea-
surement with the exposure pulses, an unwanted dose deposition was avoided during signal
readout. With these measures, we achieved an air-kerma of 0.54 mGy measured at the patient
position. This corresponds to an effective dose value larger by a factor of 3.6 compared to a
clinical PA thorax acquisition and to a similar value obtained in combined investigations
(PA&LAT). This comparison was estimated by using a thorax specific air kerma conversion
that was calculated by help of the conversion factors given in ICRP 103 [27] and the organ
doses from Drexler et al. [28] (0.095 mSv/Gy cubic interpolated to obtain a value for 70kVp).
The air kerma was measured with a PTW NOMEX dosimeter (PTW, Freiburg, Germany)
combined with an air chamber sensor.
Results
In this study, we demonstrate for the first time the successful translation of X-ray dark-field
radiography from small-animal imaging systems to a setup capable of imaging human thora-
ces, including imaging parameters such as scan duration, field-of-view, and radiation dose
being appropriate for patients. Fig 3 displays the dark-field and the attenuation chest images
of a deceased human body. The investigated female body had a size and weight of 173 cm and
84 kg, respectively. The conventional X-ray image (Fig 3B) shows strong contrast between
bones and soft tissue, primarily due to increased attenuation of calcium in comparison to ligh-
ter organic materials. The lungs exhibit a very low signal, as their main constituent is low
attenuating air. In the dark-field channel (Fig 3A), a distinct pulmonary signal is measured
originating from lots of high difference of the refractive index (air to tissue) along the beam
X-ray dark-field imaging of the human lung—A feasibility study on a deceased body
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path. This variation directly correlates with the microarchitecture of the lung parenchyma.
Inherently, the two images are perfectly registered as their information is extracted from the
same dataset recorded within one pixel. In the imaging process the interferometer is constantly
scanned relative to the body’s chest while the detector acquires consecutive intensity
recordings.
For reasons of comparison and verification of our results, we conducted additional imaging
with a clinical CT system (Brilliance iCT, Philips Healthcare, USA). Correlating well with CT
scan results, autopsy revealed pulmonary edema due to cardiac arrest (Fig 4). Areas of low
dark-field signal correlated with ground-glass opacities in the CT images where an accumula-
tion of fluid reduces air-tissue-interfaces leading to a decrease of X-ray ultra small-angle scat-
tering. In contrast, a slightly increased dark-field signal was monitored in better inflated areas
of lung parenchyma. On this note, these results are obtained from a lately deceased body and
an increased image quality can be expected in living subjects imaged in standing position.
With respect to the observed changes in the present dark-field images, this is consistent with
results obtained in mice with structural lung parenchyma changes either due to loss of pulmo-
nary tissue (in the case of emphysema) or the replacement with fibrotic tissue (in pulmonary
Fig 3. Dark-field and conventional human chest radiography images of a deceased body. Anteroposterior (AP) X-
ray dark-field (A) and absorption (B) contrast images acquired with the scanner described in the materials and
methods section. We measured a slight decrease in the dark-field signal intensity in the regions highlighted by the
marker, indicating an edema (consistent with the findings in the autopsy and CT investigation, see Fig 3). This
behaviour illustrates the signal formation mechanism, because the water in the lung reduces the contrast between the
air-tissue interfaces, and subsequently reduces the ultra small-angle scattering (dark-field) signal.
https://doi.org/10.1371/journal.pone.0204565.g003
Fig 4. Computed tomography (CT) human chest images of a deceased body showing pulmonary edema due to
cardiac failure. Coronal CT image (A) at a level dorsal to the tracheal bifurcation and axial CT image (B) of the lower
lobes. The pulmonary edema indicated by the markers presents as diffuse ground-glass opacities with a predominant
perihilar distribution. Both images: 3 mm slice thickness, window level -600 HU, window width 1700 HU.
https://doi.org/10.1371/journal.pone.0204565.g004
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fibrosis). While, in contrast to pulmonary emphysema or fibrosis, the fluid accumulation in
pulmonary edema does not represent permanent structural changes to the lungs, it neutralizes
the air-tissue interfaces essential for the formation of the dark-field signal. The effect of fluid-
filled regions in porous media has already been investigated in materials science. Yang et al.
could show that in time-lapse X-ray dark-field contrast radiographs of a mortar during capil-
lary imbibition from the bottom, the wetting front was visible due to the decrease of the dark-
field signal [29].
At the current stage the preclinical data on X-ray dark-field imaging of the lungs suggests a
decrease in intensity of the dark-field signal as a nonspecific but very sensitive indicator for
pulmonary pathologies that affect the typical structure of air-tissue-interfaces in healthy lung
parenchyma. This observation is supported by the aforementioned recent study investigating
dark-field imaging in a mouse model of neonatal lung injury due to mechanical ventilation
and supplementation of oxygen-enriched gas [18]. Additionally, in a mouse model of lung
cancer, regions with cancerous tissue show a reduced air:tissue volume ratio due to uncon-
trolled cell proliferation and loss of alveolar space and therefore X-ray scattering is strongly
reduced [30]. Based on previous publications in small-animal models, it is unlikely that the
overall conclusions of our study are compromised by the fact that imaging was performed on a
dead human body rather than living subject. As post-mortem changes to the lungs start imme-
diately after death, with an attenuation gradient of ground-glass opacities in the dependant
lung regions described as a typical finding, it can be assumed that the dark-field signal will be
higher in living subjects. Yet, the influence of depth of inspiration on the magnitude of the X-
ray dark-field signal has to be addressed in a clinical study. Our system’s current imaging time
of approximately 30 seconds is long compared to exposure times of typically less than a second
in clinical radiography. This is due to image acquisition being performed in a scanning mode,
but can be reduced to clinically compatible exposure times with the development of gratings
covering the entire field-of-view. The development of larger gratings, which cover the full
field-of-view, is currently investigated and advances can be expected in the near future. In the
meantime, every intermediate increase in grating size reduces the acquisition time. Further
techniques used in the early days of spiral lung CT can be applied to reduce motion artefacts.
The air-kerma of 0.54 mGy was measured at the patient position. This exposure corre-
sponds to an estimated radiation dose deposited for one X-ray dark-field image, as shown in
Fig 3, being about four times higher compared to a standard clinical chest X-ray (PA) and
roughly similar compared to combined investigations (PA&LAT). However, our setup
acquires dark-field and conventional attenuation (and differential phase) images at the same
time.
Discussion
With respect to lung diagnostics, studies have estimated that 60–85% of the general population
suffering from COPD, mainly those with mild to moderate symptoms, have not been diag-
nosed [31]. COPD is not curable; however, the substantial morbidity and mortality resulting
from under-diagnosis could be prevented since COPD is a treatable disorder [32]. For exam-
ple, if detected early, smoking cessation can substantially slow disease progression. Spirometry
is commonly used to diagnose COPD, but it is highly dependent on the patient’s cooperation
and effort. Conventional chest radiographs have poor to moderate sensitivity, particularly in
patients with mild to moderate emphysema, and cannot be used to reliably assess emphysema
severity. However, the presented results in a lately deceased body demonstrate that X-ray
dark-field imaging of the human lung is feasible. It is obvious that X-ray dark-field radiogra-
phy is not limited to COPD imaging. Its high sensitivity for visualizing the integrity of healthy
X-ray dark-field imaging of the human lung—A feasibility study on a deceased body
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lung parenchyma creates many opportunities in the field of pulmonary imaging. Yet, issues
like the influence of body size/composition and breathing position on X-ray dark-field imag-
ing have to be further investigated.
In this study, we demonstrated that X-ray dark-field radiography is capable of visualizing
the dark-field signal of the lung in human sized chests. Additionally, the concept how dark-
field signal strength is influenced by pathological findings in the lungs is supported by correla-
tions with CT imaging. Further studies on deceased bodies will enable the technology to
mature for living subjects and clinical application. However, large scale clinical studies will be
necessary to investigate the full potential of X-ray dark-field radiography for pulmonary medi-
cine. It will be essential to demonstrate that X-ray dark-field radiography has the potential to
considerably improve lung diagnostics with a focus on COPD, allowing early detection and
monitoring of the disease process.
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